News

Investing Snacks3h
AbbVie Tests Oral Drug for Severe HS in New Study
AbbVie is testing its oral drug upadacitinib in a Phase 3 trial for patients with hidradenitis suppurativa (HS) who failed ...
Men with hidradenitis suppurativa perceive better physician communication
Male patients with hidradenitis suppurativa (HS) perceive better physician communication with respect to demonstrating ...
The American Journal of Managed Care14h
Approved Hidradenitis Suppurativa Treatments and Pipeline Show Similar Efficacy, Safety Without Head-to-Head Trials
Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...
Infectious Disease Advisor16h
TNF-α Inhibitors Do Not Affect COVID-19 Vaccine Response in Patients With HS
The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.